Preparation and in-vitro evaluation of an antisense-containing cationic liposome against non-small cell lung cancer: A comparative preparation study

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue SUPPL., 2013, Pages 1-8

  Saffari, Mostafa ^a   Shirazi, Farshad H ^a,c   Oghabian, Mohammad Ali ^b   Moghimi, Hamid Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytotoxicity; Ethanol injection; Gene delivery; Liposome; Thin film hydration

Indexed keywords

1, 2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ALCOHOL; ANTISENSE OLIGONUCLEOTIDE; LIPOSOME; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; HUMAN; HUMAN CELL; IC 50; INJECTION; LC 50; LUNG NON SMALL CELL CANCER; MICROTITER PLATE ASSAY; MORPHOLOGY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84875188880     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Di Maio M, Morabito A, Piccirillo MC. Daniele G. Giordano P, Costanzo R. Riccardi MG, Rocco G. Nonnanno N and Perrone R New dnigs in advanced non-small-cell lung cancer: searching for the correct clinical development. Expen Opin. Imesiig. Drugs. (2010) 19:1503-14.
2. Davies AM, Gandara DR, Lara PN, Mack PC, Lau DH and Gmnerlock PH. Antisense oligonucleotides in the treatment of non-small-cell lung cancer. Clin. Lung Cancer. (2003) 4: 68-73.
3. Cogoi S, Suraci C, Del Terra E, Diviacco S, van der Marel G, van Boom J, Quadrifoglio F and Xodo L. Down regulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells. Anrisense Nucleic Acid Drug Dev. (2000) 10: 283-95.
4. Stuart DD and Allen TM. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta. (2000) 1463: 219-29.
5. Dominska M and Dvkxhoom DM. Breaking down the barriers: siRNAdelivery and endosome escape. J. Cell. Sci. (2010) 123:1183-9.
6. Carter G and Lemoine NR. Antisense technolog)' for cancer therapy: does it make sense? Br. J. Cancer. (1993) 67: 869-76.
7. Kamimura K, Suda T. Zhang G and Liu D. Advances in Gene Delivery Systems. Pharmaceut. Med. (2011) 25: 293-306.
8. Tan Y, Whitmore M, Li S. Frederik P and Huang L. LPD nanoparticles-novel nonviral vector for efficient gene delivery. Methods Mol. Med. (2002) 69: 73-81.
9. Pupo E, Padrón A, Santana E, Sotolongo J, Quintana D, Dueñas S, Duarte C, de la Rosa MC and Hardy E. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization--extrusion technique. J. Control. Release. (2005) 104: 379-96.
10. Semple SC, Klimuk SK, Harasym TO, Dos Santos N, Ansell SM, Wong KF, Maurer N, Stark H, Cullis PR, Hope MJ and Scherrer P. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim. Biophys. Acta. (2001) 1510: 152-66.
11. De Rosa G, De Stefano D, Laguardia V, Arpicco S, Simeon V, Carnuccio R and Fattal E. Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages. Eur. J. Pharm. Biopharm. (2008) 70: 7-18.
12. Liu F, Conwell CC, Yuan X, Shollenberger LM and Huang L. Novel nonviral vectors target cellular signaling pathways: regulated gene expression and reduced toxicity. J. Pharmacol. Exp. Ther. (2007) 321: 777-83.
13. Schmidt D, Jiang QX and MacKinnon R. Phospholipids and the origin of cationic gating charges in voltage sensors. Nature. (2006) 444: 775-9.
14. Lahn M, Su C, Li S, Chedid M, Hanna KR, Graff JR, Sandusky GE, Ma D, Niyikiza C, Sundell KL, John WJ, Giordano TJ, Beer DG, Paterson BM, Su EW and Bumol TF. Expression levels of protein kinase C-alpha in non-small-cell lung cancer. Clin. Lung Cancer. (2004) 6: 184-9.
15. Song HF, Tang ZM, Yuan SJ, Zhu BZ and Liu XW. Antisense candidates against protein kinase-α designed on phylogenesis and simulant structure of mRNA. Acta Pharmacol. Sin. (2003) 24: 269-76.
16. Willis MC, Collins BD, Zhang T, Green LS, Sebesta DP, Bell C, Kellogg E, Gill SC, Magallanez A, Knauer S, Bendele RA, Gill PS and Janjic N. Liposome-anchored vascular endothelial growth factor aptamers. Bioconjugate Chem. (1998): 573-582.
17. Stewart JC. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem. (1980) 104: 10-4.
18. Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, Barkhordari F, Khamesipour A and McMaster WR. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Vaccine. (2006) 24: 5708-17.
19. Peng J, He X, Wang K, Tan W, Li H, Xing X and Wang Y. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Nanomedicine. (2006) 2: 113-20.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. (1983) 65: 55-63.
21. Franken NA, Rodermond HM, Stap J, Haveman J and van Bree C. Clonogenic assay of cells in vitro. Nat. Protoc. (2006) 1: 2315-9.
22. Rahman A, Panneerselvam M, Guirguis R, Castronovo V, Sobel ME, Abraham K, Daddona PE and Liotta LA. Anti-laminin receptor antibody targeting of liposomes with encapsulated doxorubicin to human breast cancer cells in vitro. J. Natl. Cancer. Inst. (1989) 81:1794-800.
23. Akhtar S, Kole R and Juliano RL. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. (1991) 49: 1793-801.
24. Tamaddon AM. Effect of some lipid bilayer-destabilizers on release of antisense oligodeoxynucleotides from cationic liposomes and their cytotoxicity [dissertation]. Tehran, Shahid Beheshti University of Medical Sciences (2006) 208-238.